Newsroom | 5254 results

Sorted by: Latest

Diabetes
-

Im Anschluss an die HIV-Konferenz der Vereinten Nationen fordert die AHF dazu auf, Ressourcen zum Einhalten der Versprechen bereitzustellen

LOS ANGELES--(BUSINESS WIRE)--Die AIDS Healthcare Foundation (AHF) begrüßte das Engagement der Mitgliedstaaten auf der hochrangigen Konferenz der Vereinten Nationen zum Thema HIV/AIDS, unterstrich jedoch gleichzeitig, dass Millionen von Menschen, die mit HIV leben, noch immer keinen Zugang zu lebensrettender Behandlung haben und dass schätzungsweise 1,2 Millionen Menschen jedes Jahr an HIV erkranken. Während Regierungen ihr Engagement für die Beseitigung von AIDS als Bedrohung der öffentlichen...
-

À l’issue de la réunion des Nations unies sur le VIH, AHF appelle à ce que les ressources soient à la hauteur des promesses

LOS ANGELES--(BUSINESS WIRE)--AIDS Healthcare Foundation (AHF) s’est félicité de l’engagement des États membres lors de la réunion de haut niveau des Nations unies sur le VIH/sida de 2026, tout en soulignant que des millions de personnes vivant avec le VIH n’ont toujours pas accès à un traitement vital et qu’environ 1,2 million de personnes contractent le VIH chaque année. Alors que les gouvernements réaffirment leur engagement à mettre fin au sida en tant que menace pour la santé publique, AHF...
-

Walgreens Pharmacists Help Medicare Patients Navigate New Access to GLP‑1 Medications

DEERFIELD, Ill.--(BUSINESS WIRE)--Walgreens is supporting the more than 56 million patients in the Medicare network that may be eligible for GLP-1 medications through the Medicare GLP-1 Bridge program. Walgreens pharmacists will help eligible Medicare patients navigate the new program at nearly 8,000 stores across the country. To get started, patients should speak with their healthcare provider about whether they may be eligible. The Medicare Bridge program is a new nationwide initiative from t...
-

Insulet Announces Appointment of Jonathan J. Mazelsky to its Board of Directors

ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced the appointment of Jonathan (“Jay”) Mazelsky to the Company’s Board of Directors, effective July 1, 2026. Mr. Mazelsky joins the Board as an independent director. “We are pleased to welcome Jay to Insulet’s Board of Directors,” said President and CEO Ashley McEvoy. “Jay has a strong track record of...
-

After UN HIV Meeting, AHF Calls for Resources to Match Promises

LOS ANGELES--(BUSINESS WIRE)--AIDS Healthcare Foundation (AHF) welcomed the engagement of Member States at the 2026 United Nations High-Level Meeting on HIV/AIDS, while emphasizing that millions of people living with HIV still do not have access to lifesaving treatment, and an estimated 1.2 million people acquire HIV each year. As governments reaffirm their commitment to ending AIDS as a public health threat, AHF urged that political promises be matched by the resources needed to turn commitmen...
-

Anodyne Nanotech Closed a $12.6 Million Series A to Advance Once-Weekly GLP-1 Patch into Phase I Clinical Trials

BOSTON--(BUSINESS WIRE)--Anodyne Nanotech Inc., a clinical-stage biotechnology company simplifying chronic care through transdermal delivery, today announced the closing of a $12.6 million Series A financing. The round was led by Velocity Partners VC and co-led by Evercurious VC, with major participation from Relativity Healthcare Partners. Proceeds from the financing will support the advancement of ANN-101, Anodyne's once-weekly GLP-1 patch for obesity, into a Phase I clinical trial, while acc...
-

Olio Releases New Report on the Future of Skilled Nursing

INDIANAPOLIS--(BUSINESS WIRE)--Summit of SNF leaders representing more than 350 facilities identifies clear path forward for operators to take control of transitions of care....
-

SNO and OpenEvidence Launch Official Generative AI Partnership

MIAMI & HOUSTON--(BUSINESS WIRE)--The Society for Neuro-Oncology (SNO), the world's largest multidisciplinary organization dedicated to advancing research, education, and clinical care for patients with brain and spinal cord tumors, and OpenEvidence, the leading AI-powered clinical decision support platform, today announced a landmark partnership, designating OpenEvidence as SNO's official generative AI partner. As part of the collaboration, SNO will embed OpenEvidence across its member-facing...
-

Dexcom Further Advances Vision of Glucose Biosensing for All

SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ: DXCM), the global leader in glucose biosensing, today announced at Aspen Ideas: Health a series of milestones that advance its vision of making glucose biosensing more accessible. Notably, the company announced pediatric clearance for the Stelo Glucose Biosensor and the launch of its fully reimagined Stelo app experience in July for Apple iPhone and Android users in the United States.“Glucose matters for everyone and better understanding it can h...
-

Latest Study Shows Signos Drives Up to 7% Weight Loss Over 6 Months, Rivaling Real-World GLP-1 Weight Loss

PALO ALTO, Calif.--(BUSINESS WIRE)--Signos announces results from real-world study evaluating weight loss in adults with obesity using the Signos System with Dexcom CGM....